As we forge forward through the second half of 2019, many of the catalysts that once seemed over the horizon draw nearer. Here is my list of notable readouts from companies that I follow and/or are on … [Read more...] about My End of 2019 Notable Readouts
Sesen Bio (SESN) is down over 50% from its early summer highs, but the company is moving toward an inflection point. As disclosed earlier this year, Sesen has had several productive meetings with the … [Read more...] about Sesen Bio: The Accelerated Approval Misunderstanding
The previous earnings report from Verastem (VSTM) was filled with volatility and surprises. As I outlined in my last piece, Verastem's Earnings - Is It a Buy Now?, Verastem is a company filled with … [Read more...] about Another Quarter of Growth for Verastem…Is It Enough?
Previously, our Chief Operating Officer Sultan Beardsley outlined an investment thesis for RegenXBio. This detailed report can be read here: Could This Biotech Stock Get Bought For $5.5 Billion? … [Read more...] about An Update on RegenXBio
Now that we are in the heat of summer the books have closed for the first half of the year. Here in the exclusive piece for our subscribers in which our team will individually reflect on our first … [Read more...] about MS Conference Call Exclusive: Reflecting on the 1st Half of 2019
Tumor-agnostic therapy is the idea that a molecular or genetic alteration in a tumor can be targeted by a therapy, regardless of the tumors location in the body (link). This requires that the tumor be … [Read more...] about Tumor-Agnostic Therapy: LOXO…Array…Now Who?
Here is a brief summary of recent, yet important developments for Calithera (CALA), TG Therapeutics (TGTX) and Array Biopharma (ARRY) that may impact your investments and trades. Calithera On … [Read more...] about INVESTOR ALERT: Calithera, TG Therapeutics, and Array Biopharma
In this video; Chris Stang MS CPO provides education on the different kinds of Oncology present in todays market. Be sure to Subscribe for the next lesson! … [Read more...] about Oncology Lesson 2
Whether you use Yahoo Message Board, SeekingAlpha, or StockTwits, these forums have similar benefits and drawbacks. First, they allow for the transfer, discussion, and debates on thoughts and data … [Read more...] about How to Approach Investor Forums
Here, in part one of our new series, I will discuss chemotherapy agents. Included will be a brief discussion on how they work, common drugs, and their common side effects. … [Read more...] about Types of Oncology Therapies Part 1: Chemotherapy